Cargando…
Anti-insulin growth factor receptor therapy in Ewing sarcoma
The insulin-like growth factor (IGF) signal transduction pathway appears to play a key role in the development and proliferation of the Ewing sarcoma family of tumors. Integration of anti-IGF-1 receptor therapy into the standard treatment for these patients is a novel approach that will likely be in...
Autores principales: | Isakoff, Michael S, Marina, Neyssa |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medicine Reports Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948310/ https://www.ncbi.nlm.nih.gov/pubmed/20948718 http://dx.doi.org/10.3410/M1-62 |
Ejemplares similares
-
Targeting the Insulin-Like Growth Factor 1 Receptor in Ewing's Sarcoma: Reality and Expectations
por: Olmos, David, et al.
Publicado: (2011) -
Targeted Therapy in Ewing Sarcoma
por: Lissat, A., et al.
Publicado: (2012) -
Targeted Therapy of Ewing's Sarcoma
por: Subbiah, Vivek, et al.
Publicado: (2011) -
Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children’s Oncology Group (COG) New Agents for Ewing Sarcoma Task Force
por: Bailey, Kelly, et al.
Publicado: (2019) -
Recent advances in targeted therapy for Ewing sarcoma
por: Pishas, Kathleen I., et al.
Publicado: (2016)